Clinical Trials Directory

Trials / Completed

CompletedNCT06425757

Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Xie Kangjie · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Blood concentrations of Ciprofol were measured at different time points after single injection in patients with hypoproteinemia

Detailed description

This study was a single-center, interventional clinical study. Patients with different plasma albumin levels were selected before surgery and induced by a single injection of Ciprofol at a depth of 0.3 mg/kg. 2ml of venous blood was collected before and 0.5, 1, 2, 3, 5, 8, 15, 30min, 1h, 2h and 4h after administration. The pharmacokinetics of Ciprofol were studied by measuring the concentration of Ciprofol in blood.

Conditions

Interventions

TypeNameDescription
DRUGciprofolPatients who intended to undergo elective surgery under general anesthesia were induced by a single intravenous injection of 0.3mg/kg and ciprofol, and the experimental drug was manually injected by CVC within 30s. 2ml of venous blood was collected before and after administration 0.5min, 1min, 2min, 3min, 5min, 8min, 15min 30min, 1h, 2h and 4h respectively. The concentration of cyclopofol in blood was measured

Timeline

Start date
2024-04-04
Primary completion
2025-04-30
Completion
2025-08-30
First posted
2024-05-22
Last updated
2025-10-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06425757. Inclusion in this directory is not an endorsement.